Magazine - Pharmacy Technician Pulse

Bath researchers develop pill-based alternative to injections

Pharma Times

AUGUST 5, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

PharmaShots Magazine-June-2025 Edition

PharmaShots

JUNE 12, 2025

The July Edition of PharmaShots Magazine will revolve around the topic “Unlocking the Future: Insights into Regenerative Medicine” and the August Edition will focus on the Cosmeceutical Industry. Send us your promotional pieces at connect@pharmashots.com The post PharmaShots Magazine-June-2025 Edition appeared first on PharmaShots.

Ovagen breakthrough boosts yellow fever vaccine yields

Pharma Times

JULY 23, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Vaccines

Gedeon Richter launches Nalvee in UK to expand HRT options for menopause

Pharma Times

AUGUST 5, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Porosome Therapeutics unveils breakthrough Alzheimer’s research

Pharma Times

AUGUST 6, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

FDA

PhoreMost unveils platform to streamline molecular glue drug discovery

Pharma Times

JULY 22, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

FDA

Osivax publishes phase 2a results supporting dual flu vaccine approach

Pharma Times

JULY 10, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Vaccines

Vaccines Immunization

Pharmaceutical Technology Excellence Awards 2025: i3 Membrane

Pharmaceutical Technology

JUNE 24, 2025

Can pharma tariffs “Make America Manufacture Again”?

Packaging

Packaging Pharmaceutical Companies Pharmaceutical Companies

FDA approves AJOVY for paediatric migraine prevention

Pharma Times

AUGUST 13, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

FDA

Flow state: The evolving shape of continuous manufacturing

Pharma Manufacturing

JUNE 17, 2025

Magazine ENEWS SUBSCRIBE WEBINARS PODCASTS EBOOKS ABOUT US Edit submissions Media kit Innovation Awards Articles Flow state: The evolving shape of continuous manufacturing June 17, 2025 While the pharmaceutical industry has been slow to adopt continuous manufacturing, it appears to be gaining momentum.

Dosage

Dosage FDA Packaging

How AI and machine learning are transforming drug discovery

Pharmaceutical Technology

JUNE 26, 2025

Can pharma tariffs “Make America Manufacture Again”?

Compounding

Compounding Communication Packaging Labelling

MHRA approves first oral treatment for hereditary angioedema attacks

Pharma Times

JULY 15, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

FDA expands AVTOZMA IV approval to include cytokine release syndrome

Pharma Times

AUGUST 7, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

FDA

FDA Immunization

UK enacts law to decentralise manufacture of personalised treatments

Pharmaceutical Technology

JULY 23, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Communication

Communication Hospitals Packaging Insurance

NHS England secures access to new cystic fibrosis treatment ALYFTREK

Pharma Times

JULY 15, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Sever Pharma expands work on ketamine implant with Silo Pharma

Pharma Times

AUGUST 11, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

FDA

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

Pharmaceutical Technology

JUNE 25, 2025

Can pharma tariffs “Make America Manufacture Again”?

FDA

FDA Packaging Communication Hospitals

Vutrisiran marks first silencer approved for ATTR-CM

Pharmaceutical Technology

JUNE 12, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Packaging Insurance

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Insurance Coverage

UCB reports success in phase 3 study of fenfluramine for CDD

Pharma Times

JUNE 30, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023 This field is required.

Labelling

GSK’s world-first gonorrhoea vaccine launched in England

Pharmaceutical Technology

AUGUST 5, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Vaccines

Vaccines Communication Hospitals Packaging

Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression

Pharma Times

JULY 17, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Labelling

Mosanna Therapeutics gains $80m to advance OSA nasal spray

Pharmaceutical Technology

JUNE 10, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Packaging Insurance

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

JULY 4, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Chemotherapy

Chemotherapy Packaging Communication Hospitals

Hengrui Pharma and GSK link across key therapeutic areas

Pharmaceutical Technology

JULY 28, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Packaging

Packaging Communication Hospitals Insurance

Insmed wins FDA approval for future blockbuster Brinsupri

Pharmaceutical Technology

AUGUST 13, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

FDA

FDA Packaging Communication Hospitals

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

JUNE 13, 2025

Can pharma tariffs “Make America Manufacture Again”?

Vaccines

Vaccines Communication Hospitals Packaging

Cidara and hVIVO report positive results in flu prevention study

Pharma Times

JUNE 30, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023 This field is required.

Vaccines

Vaccines FDA

Ethris and Thermo Fisher partner on mRNA solutions

Pharmaceutical Technology

JUNE 16, 2025

Can pharma tariffs “Make America Manufacture Again”?

Vaccines

Vaccines Communication Hospitals Packaging

Neumifil shows promise in treating influenza with positive phase 2 dat

Pharma Times

JULY 2, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Vaccines

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies

Pharmaceutical Technology

JUNE 27, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Communication

Communication Packaging Hospitals Vaccines

FDA approves label updates for BMS’ CAR T cell therapies

Pharmaceutical Technology

JUNE 27, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Labelling

Labelling FDA Packaging Communication

Kling Bio partners with Sanofi to accelerate antibody discovery

Pharma Times

JULY 24, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Vaccines

Vaccines Immunization

eXmoor and Signadori Bio enter cell therapy partnership

Pharma Times

JUNE 19, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023 This field is required.

FDA

EC approves argenx’s efgartigimod alfa for CIDP treatment

Pharmaceutical Technology

JUNE 23, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Packaging Insurance

Juvenescence enhances AI drug discovery with Ro5 acquisition

Pharmaceutical Technology

JUNE 6, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Packaging Compounding

EC authorises Sydnexis’ paediatric myopia treatment

Pharmaceutical Technology

JUNE 6, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Packaging Insurance

Moderna’s updated COVID-19 vaccine receives positive EMA opinion

Pharma Times

JULY 28, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Moderna’s updated COVID-19 vaccine receives positive EMA opinion by John Pinching | 28th Jul 2025 | News CHMP recommends authorization for LP.8.1-targeting

Vaccines

Infectious disease screening during substance use disorder treatment increases detection, prevention, and treatment

Pharmaceutical Technology

AUGUST 15, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Vaccines

Vaccines Communication Hospitals Packaging

Amphastar and Anji make licence agreement for three new peptides

Pharmaceutical Technology

AUGUST 13, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Packaging

Packaging Communication Hospitals FDA

MetrioPharm gains orphan drug status from EMA for MP1032

Pharmaceutical Technology

JULY 30, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Packaging

Packaging Communication Immunization FDA

Great Place To Work® and Fortune Name Chiesi Group No. 23in 2024 World’s Best Workplaces™ List

Pharmafile

NOVEMBER 19, 2024

23in 2024 World’s Best Workplaces™ List appeared first on Pharmafile.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

Basilea secures rights to Venatorx’s antibiotic for complicated UTIs

Pharmaceutical Technology

AUGUST 14, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Hospitals

Hospitals Communication FDA Packaging

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

JUNE 19, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Packaging Pharmaceutical Companies

Bath researchers develop pill-based alternative to injections

PharmaShots Magazine-June-2025 Edition

Trending Sources

Ovagen breakthrough boosts yellow fever vaccine yields

Gedeon Richter launches Nalvee in UK to expand HRT options for menopause

Porosome Therapeutics unveils breakthrough Alzheimer’s research

PhoreMost unveils platform to streamline molecular glue drug discovery

Osivax publishes phase 2a results supporting dual flu vaccine approach

Pharmaceutical Technology Excellence Awards 2025: i3 Membrane

FDA approves AJOVY for paediatric migraine prevention

Flow state: The evolving shape of continuous manufacturing

How AI and machine learning are transforming drug discovery

MHRA approves first oral treatment for hereditary angioedema attacks

FDA expands AVTOZMA IV approval to include cytokine release syndrome

UK enacts law to decentralise manufacture of personalised treatments

NHS England secures access to new cystic fibrosis treatment ALYFTREK

Sever Pharma expands work on ketamine implant with Silo Pharma

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

Vutrisiran marks first silencer approved for ATTR-CM

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

UCB reports success in phase 3 study of fenfluramine for CDD

GSK’s world-first gonorrhoea vaccine launched in England

Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression

Mosanna Therapeutics gains $80m to advance OSA nasal spray

Big pharma braces for revenue headwinds as patent expiries loom

Hengrui Pharma and GSK link across key therapeutic areas

Insmed wins FDA approval for future blockbuster Brinsupri

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Cidara and hVIVO report positive results in flu prevention study

Ethris and Thermo Fisher partner on mRNA solutions

Neumifil shows promise in treating influenza with positive phase 2 dat

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies

FDA approves label updates for BMS’ CAR T cell therapies

Kling Bio partners with Sanofi to accelerate antibody discovery

eXmoor and Signadori Bio enter cell therapy partnership

EC approves argenx’s efgartigimod alfa for CIDP treatment

Juvenescence enhances AI drug discovery with Ro5 acquisition

EC authorises Sydnexis’ paediatric myopia treatment

Moderna’s updated COVID-19 vaccine receives positive EMA opinion

Infectious disease screening during substance use disorder treatment increases detection, prevention, and treatment

Amphastar and Anji make licence agreement for three new peptides

MetrioPharm gains orphan drug status from EMA for MP1032

Great Place To Work® and Fortune Name Chiesi Group No. 23in 2024 World’s Best Workplaces™ List

Basilea secures rights to Venatorx’s antibiotic for complicated UTIs

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Stay Connected